Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice: A nationwide Netherlands registry study in small cell lung cancer patients (CACIS)
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.116042 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Ilias Houda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Amsterdam UMC, location VU Medical Center, Amsterdam, the Netherlands; Cancer Center Amsterdam, de Boelelaan 1117, …. Hauptthemen laut MEDLINE: Carboplatin, Cisplatin, Small Cell Lung Carcinoma, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Amsterdam UMC, location VU Medical Center, Amsterdam, the Netherlands; Cancer Center Amsterdam, de Boelelaan 1117, Amsterdam 1081HV, the Netherlands. Electronic address: i.houda@amsterd…
- Cancer Center Amsterdam, de Boelelaan 1117, Amsterdam 1081HV, the Netherlands; Pathology, Amsterdam UMC, location VU Medical Center, Amsterdam, the Netherlands.
- Department of Pulmonary Medicine, Amsterdam UMC, location VU Medical Center, Amsterdam, the Netherlands; Cancer Center Amsterdam, de Boelelaan 1117, Amsterdam 1081HV, the Netherlands.
- Epidemiology and Data Science, Amsterdam UMC, location VU Medical Center, Amsterdam, the Netherlands.
- Department of Pulmonary Medicine, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands.
- Department of Pulmonary Medicine, Sint Antonius Ziekenhuis, Nieuwegein, the Netherlands.
Zitieren
APA
Houda, I., Naves, D., Ulas, E. B., Lissenberg-Witte, B. I., Barlo, N. P., Kastelijn, E. A., Bouhaddou, H., Shaikh, R., Dickhoff, C., Radonic, T., Schneiders, F. L., Senan, S., Damhuis, R. A. M., & Bahce, I. (2025). Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice: A nationwide Netherlands registry study in small cell lung cancer patients (CACIS). European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116042
Vancouver
Houda I, Naves D, Ulas EB, Lissenberg-Witte BI, Barlo NP, Kastelijn EA, et al. Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice: A nationwide Netherlands registry study in small cell lung cancer patients (CACIS). European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.116042
BibTeX
@article{Houda2025,
author = {Houda, Ilias and Naves, Dwayne and Ulas, Ezgi B and Lissenberg-Witte, Birgit I and Barlo, Nicole P and Kastelijn, Elisabeth A and Bouhaddou, Hicham and Shaikh, Rimsha and Dickhoff, Chris and Radonic, Teodora and Schneiders, Famke L and Senan, Suresh and Damhuis, Ronald A M and Bahce, Idris},
title = {Survival outcomes with carboplatin versus cisplatin and the impact of COVID-19 on platinum choice: A nationwide Netherlands registry study in small cell lung cancer patients (CACIS)},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.116042}
}
EUVIMED